PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY)

Aim. To perform cost-effectiveness analysis of 24 weeks antihypertensive therapy based on carvedilol or metoprolol in patients with arterial hypertension (HT) 1-2 degrees and overweight/obesity. To assess effects of carvedilol therapy on 10-year expected risk of cardiovascular complications (CVC).Ma...

Cijeli opis

Bibliografski detalji

Glavni autori:	S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
Format:	Artigo
Jezik:	Inglês
Izdano:	Столичная издательская компания 2016-01-01
Serija:	Рациональная фармакотерапия в кардиологии
Teme:	аrterial hypertension obesity carvedilol metoprolol pharmacoeconomic analysis
Online pristup:	https://www.rpcardio.online/jour/article/view/845
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!